PERIOD ENDING | 28-Dec-03 | 28-Sep-03 | 29-Jun-03 | 30-Mar-03 |
Total Revenue | 1,242,097 | 908,816 | 921,608 | 1,043,043 |
Cost of Revenue | 408,531 | 333,216 | 326,902 | 381,928 |
|
Gross Profit | 833,566 | 575,600 | 594,706 | 661,115 |
|
| Operating Expenses |
| Research Development | 149,938 | 143,297 | 135,690 | 131,801 |
| Selling General and Administrative | 170,513 | 133,706 | 117,486 | 135,724 |
| Non Recurring |
-
| (319) | 3,757 | 160,145 |
| Others | 2,875 | 2,701 | 1,951 | 1,965 |
| |
| Total Operating Expenses |
-
| 279,385 | 258,884 | 429,635 |
|
|
Operating Income or Loss | 510,240 | 296,215 | 335,822 | 231,480 |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 37,914 | 24,348 | 44,190 | (49,278) |
| Earnings Before Interest And Taxes | 548,149 | 320,717 | 380,254 | 218,755 |
| Interest Expense | 8,568 | 10,186 | 9,763 | 3,879 |
| Income Before Tax | 539,581 | 310,531 | 370,491 | 214,876 |
| Income Tax Expense | 187,288 | 19,129 | 178,802 | 111,860 |
| Minority Interest | (5) | 154 | 242 | 36,553 |
| |
| Net Income From Continuing Ops | 352,293 | 291,402 | 191,689 | 103,016 |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
Net Income | 352,293 | 291,402 | 191,689 | 103,016 |
Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
Net Income Applicable To Common Shares | $352,293 | $291,402 | $191,689 | $103,016 |
|